Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral Suspension Read more
MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative Antibody Drug Conjugate Candidates Read more
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases Read more
Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders Read more
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591 Read more
VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases Read more
AstraZeneca licenses novel agent for the treatment of cardiometabolic conditions and obesity Read more